Table 3.
Feasibility outcomes and estimated sample sizes
| Outcome | Demonstration of feasibility | Estimated actual proportion | Desired precision | Required sample size |
|---|---|---|---|---|
| Administration of first dose of albumin within two hours of furosemide administration |
Lower-bound of 95% confidence interval greater than 85% |
0.925 |
0.075 |
47 |
| Administration of at full 72 hours of study treatment |
Lower-bound of 95% confidence interval greater than 80% |
0.9 |
0.1 |
34 |
| Absence of hyperoncotic albumin in control arm |
Lower-bound of 95% confidence interval greater than 85% |
0.95 |
0.1 |
18 |
| Randomization rate of patients eligible by screening criteria | Lower-bound of 95% confidence interval greater than 50% | 0.65 | 0.15 | 39 |